Patent Assignment
Reel/Frame 045311/0168
Release of Security Interest
Recorded: 2018-03-22
Pages: 5
Assignor
SILICON VALLEY BANK
Executed: 2018-03-19
Assignee
CUTISPHARMA, INC.
841 WOBURN STREET, WILMINGTON, MASSACHUSETTS, 01887
Covered Properties
(7)
Compositions and Kits for Compounding Pharmaceuticals
Patent:
6,708,822 →
Application:
09/707,783 →
Container and Method for the Preparation, Storage and Dispensing of Compounded Suppositories
Container and Kit for the Preparation, Storage and Dispensing of Compounded Suppositories
Container and Kit for the Preparation, Storage and Dispensing of Compounded Suppositories
Compositions and Kits for Compounding Pharmaceuticals
Application:
13/628,215 →
Publication:
US 2013/0079311
Composition and Method for Vancomycin Oral Liquid
Application:
61/953,076 →
Composition and Method for Vancomycin Oral Liquid
Application:
61/992,414 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 11, 2012
From: MUNI, INDU; MUNI, GITA; PATEL, DILIP; MIONE, PETER
To: CUTISPHARMA, INC.
Reel/Frame 028528/0213 →
Assignment of Assignor's Interest
Dec 7, 2012
From: MUNI, INDU
To: CUTISPHARMA, INC.
Reel/Frame 029423/0398 →
Assignment of Assignor's Interest
May 15, 2014
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 032902/0103 →
Assignment of Assignor's Interest
Nov 13, 2014
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 034161/0613 →
Security Agreement
Dec 16, 2014
From: CUTISPHARMA, INC.; RXEDESIGNEDMEDS, LLC; RXM THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 034648/0882 →
Security Interest
Mar 21, 2018
From: CUTISPHARMA, INC.
To: GOLDMAN SACHS SPECIALTY LENDING GROUP, L.P., AS COLLATERAL AGENT
Reel/Frame 045300/0385 →
Security Interest
May 17, 2019
From: CUTISPHARMA, INC.; SILVERGATE PHARMACEUTICALS, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 049209/0272 →
Release of Security Interest
May 17, 2019
From: GOLDMAN SACHS SPECIALTY LENDING GROUP, L.P., AS COLLATERAL AGENT
To: CUTISPHARMA, INC.
Reel/Frame 049212/0549 →
Change of Name
Aug 20, 2020
From: CUTISPHARMA, INC.
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 053559/0737 →
Security Interest
Apr 16, 2021
From: AZURITY PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055938/0859 →
Release of Security Interest
Sep 20, 2021
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 057531/0403 →
Security Interest
Sep 20, 2021
From: AZURITY PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057532/0424 →
Release of Security Interest
Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
Confirmatory Grant of Security Interest in United States Patents
Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →
Termination and Release of Security Interest in Patents Recorded at Reel 049209, Frame 0272
Jun 24, 2025
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: CUTISPHARMA, INC. (N/K/A AZURITY PHARMACEUTICALS, INC.)
Reel/Frame 071704/0458 →